BackAngion Biomedica Overview

Angion Biomedica Current Cash

Angion Biomedica's current cash is $15M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$14.95M
18.54% YoYΔ $-3.40M vs prior year quarter

Peer average

Loading

Angion Biomedica Current Cash History

Loading

Angion Biomedica vs. peers: Current Cash Comparison

Loading

Angion Biomedica Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Angion Biomedica (ANGN) FAQ

As of the most recent data (March 2026), ANGN shows a current cash of $15M. That compares with $18M in the prior-year period — down 18.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANGN's current cash is now $15M (was $18M) — a 18.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Angion Biomedica is outperforming or lagging.

Tracking ANGN's current cash over time shows whether Angion Biomedica is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $18M in the prior-year period — down 18.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Angion Biomedica's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $15M) with ownership activity and broader fundamentals.

Angion Biomedica's current cash is $15M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.